Being the ultimate travel companion of a patient with uterine leiomyosarcoma

1Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Uterine fibroids are difficult to distinguish from malignant masses using standard ultrasonography; and morcellation carries the risk of disseminating occult cancer in a small but relevant group of women with an undetected uterine malignancy. In this context, we follow the progress of a woman diagnosed with uterine leiomyosarcoma after suboptimal initial surgery for an assumed fibroid. Evidence is reviewed that guided multidisciplinary tumor board decisions about optimal management approaches after local seeding and development of distant metastases, and informed treatment selection at each line of therapy. As the case study illustrates, choice of treatment for advanced soft tissue sarcomas frequently involves finding an appropriate balance between the efficacy and toxicity of available options, aiming to allow patients to maintain their normal lives. Tweetable abstract Being the ultimate travel companion of a patient with uterine leiomyosarcom.

Cite

CITATION STYLE

APA

Grignani, G., Merlini, A., & Aliberti, S. (2022). Being the ultimate travel companion of a patient with uterine leiomyosarcoma. Future Oncology, 18(29), 17–23. https://doi.org/10.2217/fon-2022-0637

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free